Citi forecasts Novo Nordisk Wegovy sales ahead of Q3
Citi projects Novo Nordisk third-quarter sales slightly above consensus, citing a strong Wegovy pill launch in the U.K., with Wegovy pill sales 16% above expectations. Citi expects adjusted operating income to be in line rather than beat.